Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

  • RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    RocketDNA Secures Major Aerial Tech Contract with Vault Minerals at WA Gold Site
    • News

  • BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    BirdDog Boosts Buy-Back Offer by 40% Ahead of ASX Delisting Vote
    • News

  • AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    AML3D Launches High-Tech U.S. Facility to Power Submarine Supply Chain
    • News

  • Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    Vection Enters $520K Agritech Deal to Build AI-Powered Farming Robot
    • News

  • Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    Unith Achieves Strong Growth in Platform Usage and Strategic Partnerships
    • News

  • FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    FBR and Samsung Heavy Industries Execute Engineering Service Agreement for Shipbuilding Automation Project
    • News

  • Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    Bioxyne Lifts FY2025 Revenue Forecast as Psychedelics and Pharma Push Gains Pace
    • News

BTC Health secures $5m ECMO contract with Royal Children’s Hospital for life-saving medtech

  • In News
  • September 24, 2024
  • Alfred Chan
BTC Health secures $5m ECMO contract with Royal Children’s Hospital for life-saving medtech

Following a highly competitive tender process, medical distribution company BTC Health (ASX: BTC) has secured a $5 million contract with the Royal Children’s Hospital (RCH), continuing a run of successes since undertaking a business transformation 12 months ago to diversify its product portfolio. 

This five-year RCH contract marks the first implementation of the Eurosets ECMOLIFE equipment in Australia, to be fully integrated into the hospital’s paediatric intensive care unit by the end of 2024.

ECMO is a critical life-saving technology primarily used for patients whose heart and lungs are unable to function on their own due to severe illness or injury. By taking over the function of these vital organs, ECMO temporarily allows the heart and lungs to rest and recover. The technology, though costly, is an essential part of the intensive care toolkit, providing support for some of the most vulnerable patients in critical care situations. ECMO is used in a range of conditions, from severe respiratory failure to cardiac arrest, and is recognised as one of the most complex and expensive interventions available, with each admission costing an average of $305k. 

The contract with RCH is a major step forward for BTC Health as part of its ongoing transformation over the past 12 months. The company has diversified its product portfolio after facing disruption in April 2023, when its largest supplier, Avanos Medical, discontinued the supply of its acute pain infusion products to Australia and New Zealand. These products had previously accounted for around 80% of BTC’s revenue, forcing the company to firstly find alternatives for the infusion pumps before expanding its product catalogue to reduce future risk. This diversification strategy has been particularly targeted by BTC, which has undertaken extensive research into medical devices and products that are highly popular amongst medical professionals around the world but have never made their way onto Australian shores. 

BTC Health has undergone a dramatic turnaround since consolidating its business and reducing single-party risk. The company has secured exclusive distribution partnerships with eight new international product manufacturers. This diversification has significantly broadened BTC’s product offering, more than doubling the number of products it distributes to 132 by the end of FY24, up from just 57 the previous year.

The introduction of the Eurosets ECMOLIFE equipment, alongside other new medical devices, reflects BTC Health’s commitment to establishing a more resilient and growth-oriented business. This effort has already yielded positive financial results, with BTC reporting a 5.1% increase in revenue to $8.2 million for FY24, alongside a $0.5 million improvement in earnings, bringing the company closer to breaking even. Importantly, BTC Health’s transformation has been underpinned by disciplined cost controls, allowing the company to strengthen its financial position while expanding its product offerings.

“Partnering with RCH and supporting their expert team in caring for vulnerable children is an absolute privilege,” said BTC Executive Chairman Dr Richard Treagus. This is the first implementation of our high-quality ECMOLIFE equipment in Australia, and we are excited about the opportunity to expand our national rollout further.”

As BTC Health continues to grow its product portfolio and enhance its distribution capabilities, the company is well-positioned to further capitalise on new opportunities within the medical technology sector. 

Beyond RCH, other customers within BTC’s distribution network of major hospitals include Healthscope, Ramsay Health Care, Cabrini and all State Governments across Australia. 

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  •  
  •  
  •  
  •  
  • asx btc
  • btc health
  • ECMO
  • healthcare
  • medical devices
  • Richard Treagus
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    February 13, 2025, 6:04 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/pediatric-medical-device

    Reply
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.